Abstract
leukin-6; tumour necrosis factor; biocompatibility; in vitro study Background. Conventional lactate-buffered peritoneal dialysis fluids containing glucose as the osmotic agent have been shown to compromise important peritoneal host defence functions. The current study employed Introduction an in vitro model using activated peripheral blood mononuclear leukocytes (PBMC ) for the preclinical
The continuous absorption of glucose from the peritonbiocompatibility assessment of a novel bicarbonateeal cavity of patients treated with continuous ambulatbuffered peritoneal dialysis fluid containing 1.0% ory peritoneal dialysis may lead to the development of amino acids as the osmotic agent.
obesity and hyperdyslipidaemia [1, 2] whereas at the Methods. PBMC (5×106/ml ) were pre-exposed same time, loss of amino acids and proteins into the ( 10-30 mm, 37°C ) to bicarbonate-buffered 1% aminoperitoneal dialysate may contribute to negative nitroacid solution, bicarbonate-or lactate-buffered 1.5% gen balance and malnutrition [3, 4] . An elegant way to glucose fluid, or control medium (RPMI ). The cells ameliorate both problems could be the substitution of were then washed and stimulated for 2 h at 37°C in glucose by amino acids as the osmotic agent. Indeed, RPMI containing 100 ng/mI E.coli endotoxin from earlier studies using a lactate-buffered amino-acid solustrain O55:B5. The cytokines IL-6 and TNFa in cell tion have shown its clinical feasibility and efficacy supernatants were assessed using specific enzyme [5] [6] [7] [8] [9] [10] . immunoassays, cytokine mRNA expression by reverse
In addition to these clinical considerations, the transcription polymerase chain reaction.
potential bioincompatibility of current dialysis fluids Results. Short, i.e. 10 min, exposure to conventional, has gained increasing interest of researchers in the lactate-buffered glucose fluid resulted in a significant field of peritoneal dialysis. The background of these and time-dependent inhibition of cytokine release and thoughts is the fact that the composition of convenmRNA expression by activated PBMC, whereas the tional peritoneal dialysis fluids is clearly unphysiologicytokine response was improved even following procal: (i) in order to achieve water ultrafiltration their longed (up to 2 h) exposure to bicarbonate-buffered osmolality is increased to 360-511 mOsm/kg by addi-1% amino-acid solution or bicarbonate-buffered 1.5% tion of high glucose concentrations (15.0-42.5 g/l ), glucose fluid.
and (ii) their pH is buffered to 5.2-5.5 with high Conclusions. Our results suggest that very short, i.e. lactate concentrations ( 35-40 mmol/l ) in order to prepotentially clinically relevant, exposure to conventional vent glucose caramelization during the industrial heat dialysis fluid impairs the cytokine response by activated sterilization process. In the past years several studies leukocytes. In this respect, the use of bicarbonatehave therefore used in vitro experimentation for the buffered solutions containing 1.0% amino acids or evaluation of potential adverse effects of these dialysis 1.5% glucose may result in improved biocompatibility fluids on various cell populations (for reviews see properties.
[11,12]). Among other things it has been shown that current dialysis fluids impair the capacity of leukocytes Key words: peritoneal dialysis; peritoneal dialysis fluids; regarding phagocytosis, oxygen radical production, bicarbonate buffer; amino acids; cytokines; interand killing of micro-organisms finding that even short ( 10-30 min) exposure to conventional dialysis fluids impairs the cytokine response of PBMC to bacterial endotoxin challenge, whereas at the same time cell function is preserved following bonate-buffered 4.25% glucose solution (Bic 30), or control exposure to Aminobic, suggests improved bio-medium (RPMI-1640, Sigma, Deisenhofen, Germany). compatibility properties of this bicarbonate-buffered Subsequently the cells were washed in RPMI and stimulated amino-acid solution.
for 2 h at 37°C in RPMI medium containing 100 ng/ml endotoxin from E.coli O55:B5 (Sigma). Parallel experiments were performed coincubating PBMC (2 h, 37°C ) in the
Materials and methods
respective fluids in order to assess maximum toxicity.
The incubation experiments were terminated by rapid centrifugation, and the supernatants were frozen (-80°C)
Peritoneal dialysis solutions until cytokine determination. Parallel experiments targeting cytokine mRNA expression were performed coincubating The composition of the test fluids is shown in Table 1 . All PBMC ( 1×l08 cells/ml ) in the different test fluids for 45 min solutions were obtained from Fresenius AG, Bad Homburg, followed by RNA extraction (see below). Germany. CAPD 2 fluid was supplied in a standard onechamber bag, the bicarbonate-buffered solutions in twochamber bags.
Determination of TNFa and IL-6 in cell supernatants
TNFa and IL-6 in cell supernatants were determined by Cell separation and incubation procedures specific enzyme immunoassay as described previously [20, 30] . For TNFa determination, microtitre strips (Nunc, PBMC were isolated from the peripheral blood of healthy volunteers by Ficoll density gradient centrifugation Wiesbaden, FRG) were coated with an affinity-purified polyclonal goat anti-human TNFa antibody (Bissendorf Bio-( Ficoll-Hypaque, Pharmacia, Uppsala, Sweden) under strictly sterile conditions ( laminar air flow) as described chemicals, Hannover, Germany) as the solid phase. TNFa in samples and standards was then detected by a sequence previously [19, 20, 29] . All reagents used for cell separation and incubation experiments were LAL negative. The PBMC of incubations with (i) a mouse monoclonal anti-human TNFa IgG antibody (Bissendorf Biochemicals, Hannover, fraction consisted of 15-30% monocytes, 60-70% lymphocytes, <10% granulocytes, and few erythrocytes and throm-Germany); (ii) a goat anti-mouse IgG antibody coupled to horseradish peroxidase (Jackson, West Grove, PA, USA), bocytes, as established by light-microscopy and dual-colour flow cytometry. Cell viability by trypan blue exclusion test and (iii) 3,3∞,5,5∞-tetramethyl benzidine substrate buffer for colour development ( Fluka, Buchs, Suisse). The TNFa conwas >95% before incubation.
Aliquots obtained from one individual donor, each con-tent of unknowns was calculated from a standard curve using recombinant human TNFa standards (Boehringer, Manntaining 5×106/ml PBMC, were used for each series of the incubation experiments. All materials used were cell culture heim, Germany) ranging from 20-2000 pg/ml. The lower detection limit of the assay was 8 pg/ml (zero mean+3 grade ( Nunc, Wiesbaden, Germany). For experiments targeting cytokine release, aliquots were pre-exposed (10-30 mm, standard deviations). No cross-reactivity with recombinant TNFb, interleukin-la IL-1a, IL-2, IL-3, IL-4, and IL-6 was 37°C ) to Aminobic bicarbonate-buffered (Bic 20), or conventional lactate-buffered (CAPD 2) 1.5% glucose fluid, bicar-observed when these cytokines were added to blank samples expression of both TNFa and IL-6 mRNA transcripts, which were markedly enhanced following stimulation
The lower detection limit of the IL-6 assay was 20 pg/ml.
No cross-reactivity with recombinant TNFa or TNFb, of control PBMC with E. coli LPS. Intact mRNA interleukin-la, IL-lb, IL-2, IL-3, and IL-4 was observed when expression was observed in cells stimulated in the these cytokines were added to blank samples in amounts up presence of either Aminobic or low-glucose, bicarbonto 50 ng/ml (recombinant cytokines were obtained from ate-buffered solution (Bic 20). In contrast, both conBritish Biotechnology, Cowley, Oxford, UK ).
ventional, lactate-buffered low-glucose fluid (CAPD 2) and high-glucose, bicarbonate-buffered solution (Bic RNA extraction, reverse transcription and polymerase 30) reduced TNFa and IL-6 mRNA expression to chain reaction (PCR) unstimulated background levels ( Figures 1, 2 ).
RNA extraction, reverse transcription, and PCR were performed essentially as described previously [29 ] . Briefly, total Effect of short fluid exposure on TNFa release from RNA was extracted from the cell pellets of the incubations activated PBMC by the RNAzol method as described by the manufacturer Unstimulated control PBMC after 10 min pre-exposure (Cinna-Biotecx Laboratories, Houston, TX, USA). One microgram total RNA was heat denatured at 95°C for 3 min in to RPMI medium followed by 2 h recovery in RPMI the presence of 100 pmol random hexamer (Pharmacia, released only background levels of TNFa ( 21± Freiburg, Germany) and cooled on ice for 2 min. The RNA 7 pg/mI, mean±SEM n=7). TNFa secretion was was reverse transcribed in a final volume of 20 ml of lx PCR markedly enhanced following LPS stimulation of con- at room temperature, 45 min at 42°C, and 5 min at 95°C.
The inhibitory effect of CAPD 2 was time dependent, PCR amplification of TNFa cDNA was carried out in a that is, further enhanced following 20 min and 30 min total volume of 50 ml (2 ml of reverse transcription product pre-exposure when stimulated TNFa release was and 48 ml master mix ( 36.25 ml H 2 O, 1.25 ml 3∞-primer reduced to 175±62 and 80±28 pg/ml respectively ( 20 mmol/l ), 1.25 ml 5∞-primer (20 mmol/l ), 4 ml nucleotide (P<0.02). On the other hand neither low-or hightriphosphate, 5 ml l0x PCR buffer, and 0.25 ml Taq polyglucose bicarbonate-buffered solution nor Aminobic merase (2.5 U, Amplitaq, ILS Ltd, London, UK)) using a Perkin-Elmer model 480 thermocycler ( Perkin-Elmer, showed a significant impairment of the TNFa response Ü berlingen, Germany). The PCR protocol was as follows: after 10 min pre-exposure; however, in the case of the first cycle, 94°C for 3 min, 55°C for 1 mm, 72°C for 1 min; hyperosmolar Bic 30 solution, a significant depression second to 24th, 25th or 32nd cycles, 94°C for 1 min, 55°C of TNFa release was observed after 20 and 30 min for 1 min, 72°C for 1 min. The final cycle was 94°C for 1 pre-exposure, whereas at the same time, cells exposed min and 60°C for 10 min. PCR was performed for 25 cycles to Bic 20 and Aminobic showed normal TNFa with a-actin, for 26 cycles with IL-6, and for 33 cycles secretion ( Figure 3 ) .
with TNFa.
One-tenth of the PCR reaction products was separated by electrophoresis on 1.5% agarose gels, stained with ethidium Effect of short fluid exposure on IL-6 release from bromide, and photographed. The negatives were scanned for activated PBMC densitometry (Scanpack System, Biometra, Gö ttingen, Germany), and the relative density of the TNFa and IL-6 Unstimulated control PBMC after 10 min pre-exposure transcripts was compared to the actin controls.
to RPMI medium followed by 2 h recovery in RPMI released only background levels of IL-6 (52±22 pg/ml, Oligonucleotide primers mean±SEM, n=5 ). IL-6 secretion was markedly enhanced following LPS stimulation of control cells
The sequences of the amplification primers were as follows:
(1133±385 pg/ml, P<0.05). In contrast, 10-min exposure of PBMC to conventional, lactate-buffered lowStatistical analysis glucose fluid (CAPD 2 ) significantly impaired the stimulated IL-6 response during the 2 h recovery period
All data was analysed on IBM PC 486-66 using SPSSB for Windows version.5.0.2 (SPSS, Munich, Germany). The (331±117 pg/ml, P<0.05). In the case of IL-6 20 and Aminobic, however, showed a significantly Unstimulated controls: (−Control). improved IL-6 response as compared to conventional, lactate-buffered CAPD 2 (P<0.05) (Figure 4 ) . of control PBMC (2175±519 pg/ml, P<0.01). The TNFa response was reduced to background levels Effect of prolonged fluid exposure on TNFa release from following 2 h of coincubation in both CAPD 2 and activated PBMC Bic 30 (87±39 pg/ml and 98±34 pg/ml respectively, P<0.01), whereas no significant change was observed Unstimulated control PBMC after 2 h incubation in RPMI released only background levels of TNFa following prolonged exposure to either Bic 20 (1413±596 pg/ml ) or Aminobic (1740±484 pg/ml ) ( 55±25 pg/ml, mean±SEM, n=10). TNFa secretion was markedly enhanced following LPS stimulation ( Figure 5 ). equilibration as well as water ultrafiltration, which cannot be perfectly mimicked in vitro. Still, in vitro models may constitute a useful tool in the preclinical biocompatibility evaluation of novel dialysis solutions since they allow for the detailed study of solution characteristics such as pH/buffer or osmolality/osmotic agent effects under tightly controlled conditions. In the current experimental setup, very short, i.e. potentially clinically relevant, exposure periods followed by a prolonged recovery phase are compared to an 'unphysiological' prolonged fluid exposure in order to also assess potential maximum cytotoxicity.
The major findings of this study are the following:
(a) Even very short, i.e. 10-min, exposure to a con- will at least take 20-30 min to reach nearly neutral tion observed with an otherwise identical lactatebuffered, low-pH solution. Longer pre-exposure Discussion periods to a high-glucose fluid, however, lead to a marked inhibition despite the neutral pH of the solution. In this respect it is important to note The current study investigated the in vitro-biocomthat unlike pH, the hyperosmolality of instilled patibility of Aminobic, a novel bicarbonate-buffered dialysis solutions is equilibrated much more amino-acid solution for peritoneal dialysis, thereby slowly, suggesting that a hyperosmolality/glucose employing an established model of LPS-activated effect is likely to occur in vivo even when bicarbon-PBMC. These cells are the circulating precursors of ate-buffered solutions with very high glucose conthe peritoneal macrophages, and are therefore believed centrations are applied. to constitute a valid target for this type of study (c) The novel, bicarbonate-buffered amino-acid solu- [11, 12] . Compared to in vitro-models using peritoneal tion Aminobic offers improved in vitro-biocommacrophages isolated from peritoneal dialysis effluent patibility properties as compared to conventional they offer several advantages: (i) they are available in fluid or high-glucose bicarbonate fluid in that essentially unlimited numbers; (ii) they have not previneither cytokine mRNA expression nor cytokine ously been exposed to dialysis solutions, which are the release are affected following short incubation, study objective; (iii) they permit the evaluation of fluid and the cytokine response remains improved even effects independent from potential influences of the after prolonged coincubation (up to 2 h). This is uraemic milieu. It has to be kept in mind, however, obviously due to the fact that the initial pH of that the direct extrapolation of data obtained during the amino-acid solution is neutral and the hyperosin vitro studies to the clinical situation of the CAPD molality is moderate (369 mOsm/kg). Moreover, patient is not allowed, since the CAPD cycle in vivo constitutes a dynamic cascade of events involving fluid the high concentrations of amino acids present in
